Veradigm™, an Allscripts (NASDAQ:MDRX), business unit and a leader in providing next-generation healthcare data solutions and systems, is leveraging its capability to communicate directly with a broad network of ambulatory healthcare professionals (HCPs) in order to increase public awareness and access to the Cancer Experience Registry. 
The first meeting of Highland Marketing's newly expanded advisory board discussed the NHS Long Term Plan and what will be needed to make it a success. Structural change, leadership, investment, spending on the right systems at the right level, and empowerment emerged as key themes. Allscripts (NASDAQ: MDRX) has appointed a new leader for its business in the UK while strengthening its focus on Europe, the Middle East and Africa. Richard Strong, who was Vice President, International Services, is taking up the new role of vice president and managing director, EMEA. 
Merck, a leading science and technology company, today announced that it has been granted Patent No. US 10,193,695 by the United States Patent and Trademark Office (USPTO). The patent relates to the formation of 'crypto-objects', a novel security procedure linking Artificial Intelligence (AI) and blockchain technology. 
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has again been named a Derwent Top 100 Global Innovator by Clarivate Analytics. Clarivate Analytics' Top 100 Global Innovators Report identifies the world's most innovative organizations, assessing each one on its ability to successfully develop valuable patented inventions that also have strong commercialization potential based on